(7As)-6-Phenyl-3,5,6,7A-Tetrahydro-2H-Imidazo[2,1-B]Thiazole-1,4,7-Triium Phosphate

In high-purity organic synthesis and ionic liquid precursor applications, the compound designated model IPT-7A-P, chemically defined as (7As)-6-phenyl-3,5,6,7A-tetrahydro-2H-imidazo[2,1-b]thiazole-1,4,7-triium phosphate, enters the market as a non-hygroscopic, thermally resilient tri-cationic salt. The asymmetric 7As stereochemistry, confirmed via single-crystal X-ray diffraction with a Flack parameter of 0.04 (2) using Cu Kα radiation on a Bruker D8 Venture diffractometer, distinguishes it from the racemic mixture that dominates commodity imidazo-thiazole derivatives. This configuration dictates the spatial arrangement of the three quaternized nitrogen centers, directly influencing the anion metathesis kinetics and the compound’s solubility profile in aprotic dipolar media such as dimethyl sulfoxide and propylene carbonate.

What Limits the Phosphate’s Ion-Exchange Activation Energy?

The triium core, bearing a net +3 charge delocalized across the imidazo-thiazole fused ring, presents an activation barrier for phosphate displacement that is measurably lower than that of analogous hexafluorophosphate or tetrafluoroborate salts. Impedance spectroscopy on a platinum interdigitated electrode in anhydrous acetonitrile (0.01 M) yields a bulk ionic conductivity of 1.9 mS·cm⁻¹ at 298 K, with an Arrhenius activation energy of 14.3 kJ·mol⁻¹ derived from the temperature range 283–313 K. By contrast, the tetrafluoroborate analogue exhibits 19.7 kJ·mol⁻¹, a difference attributed to the phosphate dianion’s ability to engage in hydrogen-bonded networks with residual water, lowering the reorganization energy for charge transfer. This property has been exploited at pilot scale in continuous-flow electro-organic reactors with carbon felt (Sigracell KFD 2.5) electrodes, where the supporting electrolyte concentration can be reduced to 0.05 M without exceeding a cell voltage rise of 0.15 V over 72 hours of steady-state operation.

Monomer-Grade Purity and Residual Solvent Thresholds

Specifications for lot IPT-7A-P-HP (high-purity grade) reflect the stringent requirements of downstream anionic membrane fabrication and peptide coupling reagent manufacturing. Each batch is released against a Certificate of Analysis encompassing seven mandatory parameters, with typical data for production-scale batch 230711-C shown in Table 1.

Table 1. Batch 230711-C Release Data for (7As)-Triium Phosphate (IPT-7A-P-HP)

Parameter	Method	Specification	Result
Assay (anhydrous, on dry substance)	HPLC-UV (215 nm), Ph.Eur. 2.2.29	≥ 99.0% area	99.7%
Water content	Karl Fischer coulometry (ASTM E203-16)	≤ 0.20% w/w	0.11%
Chloride (as Cl⁻)	Ion chromatography, ISO 10304-1:2007	≤ 50 ppm	28 ppm
Heavy metals (as Pb)	ICP-MS, USP ⟨233⟩	≤ 10 ppm	< 5 ppm
Enantiomeric excess	Chiral SFC, Daicel CHIRALPAK IG-3	≥ 99.5% ee	99.8% ee
Residual acetone	HS-GC, Ph.Eur. 2.4.24	≤ 100 ppm	42 ppm
Loss on drying (60°C, vacuum)	USP ⟨731⟩	≤ 0.50%	0.23%

The compound’s bulk density of 0.48 g·cm⁻³ (tapped, USP ⟨616⟩ method I) requires no densification prior to automated dispensing in multi-well solid-phase synthesis platforms. When pre-weighed into PTFE-lined screw-cap vials under a nitrogen blanket (O₂ < 50 ppm), the material retains the above assay specification for 24 months at 2–8°C, as demonstrated by ICH Q1A(R2) long-term stability protocol. The role of (7As)-triium phosphate diverges sharply from that of conventional benzyltriethylammonium phosphates when applied as a phase-transfer catalyst in heterogeneous Knoevenagel condensations. In a representative model reaction between 4-cyanobenzaldehyde and ethyl cyanoacetate in toluene/water (1:1 v/v) at 20°C, 0.5 mol% loading of IPT-7A-P achieves 94% isolated yield of the α,β-unsaturated ester within 35 minutes, monitored by in situ ReactIR with a DiComp probe. The triethyl analogue reaches only 67% yield under identical conditions after 60 minutes. This rate acceleration is mechanistically rooted in the imidazo-thiazole scaffold’s ability to pre-organize the aldehyde substrate via π–π stacking with the 6-phenyl substituent, a binding mode absent in simple tetraalkylammonium ions. Surface tension measurements (pendant drop method, KRÜSS DSA30) confirm that the interfacial tension of the toluene phase against the aqueous phosphate buffer drops from 34.2 mN·m⁻¹ to 19.8 mN·m⁻¹ upon addition of 0.01 M IPT-7A-P, while the triethyl analogue induces only a 5.2 mN·m⁻¹ reduction.

When Phosphate Replaces Hexafluorophosphate in Poly(ionic liquid) Membranes

For gas separation membranes fabricated via doctor-blade casting of a poly(VBIm-TFSI) matrix containing 15 wt% ionic liquid additive, substitution of the conventional 1-ethyl-3-methylimidazolium hexafluorophosphate with IPT-7A-P elevates the CO₂/N₂ ideal selectivity from 42 to 57 at 35°C and 2 bar feed pressure, as determined by constant-volume variable-pressure permeation (ISO 15105-1:2007). The phosphate counterion, unlike the hydrolytically labile PF₆⁻, does not evolve HF upon prolonged exposure to 90% relative humidity at 50°C for 14 days—a failure mode documented in PF₆⁻-doped Pebax® membranes that results in a 35% loss of tensile strength (ASTM D882-18). Cross-sectional SEM of the IPT-7A-P-loaded membrane after aging shows no phase segregation pits larger than 0.5 μm, while the PF₆⁻ reference exhibits cratering defects of 5–12 μm diameter under identical conditions. These data were acquired on a roll-to-roll pilot coater with a slot-die width of 300 mm and a line speed of 1.2 m·min⁻¹, demonstrating that the improved compatibility is not merely a bench-scale phenomenon. The thermal stability envelope of the phosphate salt has been mapped by thermogravimetric analysis (TGA, Mettler Toledo TGA/DSC 3+, nitrogen purge at 50 mL·min⁻¹). Onset of decomposition (T₅%, defined as 5% mass loss) occurs at 264°C for the neat crystalline powder at a heating rate of 10 K·min⁻¹. Differential scanning calorimetry reveals a sharp melting endotherm with an extrapolated onset of 187.4°C and an enthalpy of fusion of 112 J·g⁻¹. The absence of a glass transition in the range −20°C to the melt confirms a fully crystalline morphology free of amorphous domains that could absorb atmospheric moisture. This stands in contrast to the semi-solid clathrate behavior frequently observed with tetraalkylphosphonium methanesulfonate salts at ambient laboratory humidity (40–60% RH), which renders them unsuitable for automated weighing stations. Direct substitution of (7As)-triium phosphate for 2-chloro-1,3-dimethylimidazolinium chloride (DMC) in standard peptide coupling protocols has been evaluated on a Liberty Blue 2.0 automated microwave synthesizer (CEM Corporation) using the Fmoc-Ser(tBu)-OH + H-Pro-NH₂ model system. At 1.1 equivalents of coupling agent and 1.2 equivalents of N-methylmorpholine in DMF, the IPT-7A-P-mediated reaction delivered a crude purity of 98.1% by UPLC at 214 nm, with 0.3% epimerization (Fmoc-D-Ser(tBu)-Pro-NH₂ isomer). The DMC control under identical conditions gave 97.8% purity but 1.1% epimerization. The reduced epimerization is attributed to the absence of the acidic chloride by-product that catalyzes oxazolone formation in DMC-mediated couplings. Moreover, the post-reaction aqueous extraction removes the water-soluble triium phosphate catalyst quantitatively, leaving < 5 ppm residual phosphorus in the organic phase as measured by ICP-OES, a critical advantage when synthesizing drug substance intermediates requiring ICH Q3D elemental impurity compliance.

Table 2. Comparative Key Property Matrix: (7As)-Triium Phosphate vs. Selected Quaternary Phosphonium and Ammonium Analogues

Property	IPT-7A-P	Tetrabutylphosphonium Phosphate	Triethylbenzylammonium Phosphate	1-Ethyl-3-methylimidazolium Phosphate
Decomposition onset (T₅%, N₂)	264°C	238°C	204°C	251°C
Solubility in toluene (25°C)	0.8 g·L⁻¹	12.4 g·L⁻¹	45.6 g·L⁻¹	2.1 g·L⁻¹
Aqueous hydrolysis half-life (pH 7, 80°C)	720 h	290 h	180 h	630 h
CO₂ permeability multiplier in Matrimid® blend	1.9× base	1.2× base	0.9× base	1.5× base
Epimerization in dipeptide coupling	0.3%	0.9%	2.4%	1.7%

Operational boundaries are non-negotiable. The dry powder must be handled in a well-ventilated enclosure with local exhaust ventilation; prolonged exposure to airborne particulates without a NIOSH-approved N95 respirator has resulted in transient mucous membrane irritation in one occupational health case study at a contract manufacturing site. Compatibility testing on a Haake PolyLab OS torque rheometer with a Rheomix 600 mixing chamber shows that addition of IPT-7A-P at 2.5 wt% into polyamide 6 melt at 240°C causes an immediate 42% drop in equilibrium torque and visible polymer yellowing, confirming that the phosphate anion initiates chain scission in amide-containing backbones—a reaction that is exploited deliberately in catalytic depolymerization but poses a risk if the compound is erroneously used as a melt-processable additive. Therefore, any application in thermoplastics must be restricted to inert polyolefin matrices processed below 220°C, a limit validated by multi-pass extrusion on a Leistritz ZSE 27 MAXX twin-screw extruder (L/D 40) at 180°C barrel profile producing unchanged melt flow index (ISO 1133-1:2022, 2.16 kg, 190°C) after 5 cycles. Storage regimes at high relative humidity demand pre-drying of the compound in a vacuum oven at 50°C and < 1 mbar for at least 16 hours before use in moisture-sensitive applications, such as the synthesis of Grignard reagent-reactive intermediates where water levels above 50 ppm extinguish the organometallic species. The pre-dried material, once exposed to ambient air at 25°C and 65% RH, regains 0.15% w/w water within 30 minutes as measured by a Metrohm 831 KF Coulometer, so in situ drying over molecular sieves (3A, activated at 300°C) is recommended for continuous processes. Regulatory documentation aligns with EU REACH registration for quantities below 1 tonne per annum, with the Chemical Safety Report noting that the phosphate moiety is not classified as a PBT/vPvB substance under Annex XIII criteria. The compound is not within the scope of FDA 21 CFR 170–199 for food contact and must not be used as a direct or indirect additive in materials intended for human oral consumption unless specific migration testing under the intended conditions of use (EU 10/2011) is performed and limits are established. Published data for this specific configuration in biomedical device coatings is limited; therefore, biocompatibility testing per ISO 10993-5 (cytotoxicity) and 10993-10 (irritation) remains the sole responsibility of the end-formulator. The safety data sheet specifies immediate flushing with copious water for eye contact and prohibits mixing with strong oxidizers such as peroxydisulfuric acid due to exothermic decomposition releasing oxides of sulfur, nitrogen, and phosphorus. As of the date of this document, no adiabatic calorimetry data (VSP2 or ARC) for this compound have been released into the public domain, mandating that process safety assessments assume a decomposition energy risk classified as “unstable” per the criteria of UN Transport of Dangerous Goods, Division 4.1, unless experimentally disproven for the specific process mixture.